Full-Time

Staff ML Scientist

Integrative Phenotyping

Confirmed live in the last 24 hours

Insitro

Insitro

201-500 employees

Machine learning for drug discovery efficiency

Compensation Overview

$245k - $270k/yr

+ Annual Performance Bonus + Equity Incentive Plan

Senior

San Bruno, CA, USA

Open to hybrid candidates local to the San Francisco Bay area and remote candidates.

Category
Applied Machine Learning
Natural Language Processing (NLP)
AI & Machine Learning
Required Skills
Tensorflow
Keras
Pytorch
Machine Learning
AWS
Data Analysis
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Insitro referral from your network.

💡

Applications through a referral are 3x more likely to get an interview!

Requirements
  • Expertise in developing and deploying state-of-the art ML methods for interpreting and extracting signals and clinically-relevant insights from complex data modalities, including hands-on experience with modern multimodal ML techniques
  • Demonstrated ability to work with other ML scientists and engineers to plan, execute and deliver a full ML solution for challenging, real-world problems: sourcing and qualifying training data; designing and implementing ML models; testing & benchmarking
  • 5+ years of experience with diverse clinical data modalities, including some subset of: Imaging modalities (e.g., MRI, DEXA, CT, etc.), Clinical records, including individual demographics, drugs administered, clinical outcomes, etc., Physiological recordings (e.g., EEG, ECG, etc.), Molecular readouts, including omics from blood or tissue, Large-scale human genetic datasets
  • Experience with human physiology or disease biology (e.g., neuroscience, metabolism)
  • Publication record of meaningful, high-quality contributions in relevant ML, ML for health, computational biology, or biomedical venues
  • Experience producing high-quality, reusable ML code, including experience developing models using modern deep learning frameworks (such as PyTorch, TensorFlow, or Keras) and with cloud computing (preferably AWS)
  • Experience mentoring, coaching, and leading junior scientists
  • Passion for providing better medicine to patients in need!
Responsibilities
  • Develop and deploy ML methods for interpreting complex phenotypes, and for integrating multi-modal analyses across diverse phenotypic readouts
  • Provide technical leadership within a team of outstanding machine learning (ML) scientists
  • Collaborate with other leaders in the company to achieve important goals: Therapeutic Area and Clinical Development colleagues to develop new biomarkers for patient selection and clinical endpoints, Statistical Genetics team to associate human genetics with clinical outcomes, Corporate Development team to identify and onboard new, high-value data sets to guide our analysis, Lab scientists and with other ML teams (Imaging, Omics) to design experiments that generate datasets that are fit for purpose for machine learning, including ones generated explicitly for training ML models
  • Engineer robust, reusable platform components in partnership with the software engineering team
Desired Qualifications
  • Experience with human physiology or disease biology (e.g., neuroscience, metabolism)

Insitro specializes in drug discovery and development by using machine learning and biological tools to predict successful medicine pathways. Their predictive models aim to reduce the common failures in pharmaceutical research and development. The team, consisting of scientists and engineers, collaborates to generate data that enhances drug development efficiency. Insitro's goal is to provide pharmaceutical companies and research institutions with effective methods for discovering new drugs.

Company Size

201-500

Company Stage

Series C

Total Funding

$643M

Headquarters

San Francisco, California

Founded

2018

Simplify Jobs

Simplify's Take

What believers are saying

  • Insitro received $25 million from Bristol Myers Squibb for ALS target discovery.
  • The company raised over $600 million in venture capital funding.
  • Insitro appointed AI expert Emily Fox as Senior VP of AI/ML.

What critics are saying

  • Competition from well-funded companies like Xaira Therapeutics challenges Insitro's market position.
  • Ethical concerns in AI drug development may affect Insitro's public perception.
  • Data privacy issues could lead to regulatory challenges for Insitro.

What makes Insitro unique

  • Insitro integrates machine learning with high-throughput biology for drug discovery.
  • The company builds predictive models to accelerate target selection and drug development.
  • Insitro's team combines expertise in science, engineering, and drug discovery.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Excellent medical, dental, and vision coverage

Excellent mental health and well-being support

Open vacation policy

Access to free onsite baristas & cafe with daily lunch and breakfast

Access to free onsite fitness center

Commuter benefits

Paid parental leave

Competitive pay and 401(k) matching

Flexible work schedule (on site and remote)

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

3%

2 year growth

6%
Business Wire
Dec 18th, 2024
insitro Receives $25 Million in Milestone Payments from Bristol Myers Squibb for the Achievement of Discovery Milestones and the Selection of First Novel Genetic Target for ALS

insitro receives $25 million in milestone payments from Bristol Myers Squibb for the achievement of discovery milestones and the selection of first novel genetic target for ALS.

Stock Titan
Dec 18th, 2024
insitro Receives $25 Million in Milestone Payments from Bristol Myers Squibb for the Achievement of Discovery Milestones and the Selection of First Novel Genetic Target for ALS

insitro receives $25 million in milestone payments from Bristol Myers Squibb for the achievement of discovery milestones and the selection of first novel genetic target for ALS.

San Diego Business Journal
Jul 1st, 2024
Iambic Raises $153 Million Series B

Other competitors in the biotech space that use AI include Xaira Therapeutics, which has raised over $1 billion in funding and San Fransico-based Insitro, which has raised over $600 million in venture capital funding.

Business Wire
Apr 30th, 2024
Insitro Hires Ai And Machine Learning Visionary, Emily Fox, Ph.D., As Senior Vice President Of Ai/Ml

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, a machine learning-powered drug discovery and development company, today announced the appointment of Emily Fox, Ph.D., as senior vice president of AI/machine learning. In this role, she will oversee those areas as well as data science and computational biology, inclusive of data modalities that span genetics, omics, imaging, clinical data, and molecular design. Dr. Fox, a professor in the Department of Statistics and Department of Computer Science at Stanford University, has made groundbreaking contributions in the application of machine learning in healthcare, with her pioneering work directly translating into patient impact. "AI leaders of Emily’s caliber who simultaneously have an understanding of biology and health are rare, and we are privileged to have recruited her to lead our AI/ML teams,” said Daphne Koller, Ph.D., co-founder and CEO. “Her groundbreaking work in machine learning, alongside her track record in translating research into impactful applications in healthcare, aligns perfectly with our mission to revolutionize drug discovery through data-driven approaches

Elk Valley Times
Apr 4th, 2024
Leading Clinical Research Innovator, Amy Abernethy, M.D., Ph.D., Joins insitro Board of Directors

insitro, a machine learning-powered drug discovery and development company, today announced that Amy Abernethy, M.D., Ph.D, has joined the company's board of directors.